NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NRTI)
Viread is a prescription drug approved by the Food and Drug Administration (FDA) to treat HIV-1 infection in combination with other antiretroviral medications. Viread is approved for use in people two years and older. Viread is also referred to by its drug name, Tenofovir disoproxil fumarate, and by the abbreviation TDF. Tenofovir disoproxil fumarate is a component of the combination drugs Atripla, Genvoya, Stribild, Complera, and Truvada.
Viread is an antiviral medication of the nucleoside reverse transcriptase inhibitor (NRTI) class. Viread is believed to work by preventing HIV from replicating in cells.
How do I take it?
Prescribing information states that Viread is taken once daily.
Viread comes in tablet and oral powder forms.
The FDA-approved label for Viread lists common side effects including nausea, diarrhea, stomach pain, rash or itching, headache, dizziness, insomnia, depression, and changes in the shape or location of body fat.
Rare but serious side effects listed for Viread include lactic acidosis (a metabolic disorder), hepatomegaly (enlarged liver) with steatosis (fatty degeneration), and severe exacerbation of Hepatitis B.
For more details about this treatment, visit:
Viread – RxList
Overview of HIV Treatments – AIDS.gov